Compared to the general population, a woman with a confirmed BRCA1 or BRCA2 mutation is at greater risk of developing cancer during her lifetime—up to an 85% risk of breast cancer and up to a 40% risk of ovarian cancer. Her children, siblings and parents have a 50% chance of having the same autosomal dominant mutation and facing comparable risks.
WebinarsView All Webinars >
Attendees learn the description of big data, how laboratories have used data analytics to improve quality and create public health insights and define the new... Read more
Dr. Shamim Islam discusses latent tuberculosis infection (LTBI), Interferon Gamma Release Assay (IGRA) blood test and tuberculin skin test (TST). ASCLS P.A.C.E.® credits are available... Read more
Dr. Roberts will discuss the 9p21 genotype as a risk factor for coronary heart disease. Participants will also learn how to select patients for 9p21... Read more
Expert InsightsView All Expert Insights >
PublicationsView All Publications >
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Bandino JP, Kazlouskaya V, Ergin S, Moles-Proveda P, Cleaver NJ, Kabigting FD, Shackelton JB, Thieu K
J Cutan Pathol 2015
Determination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppression.
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Burger H, Weiser B, Gao W, Anastos K, Young M
AIDS Res Ther 2015;12:11
Use of a picosecond pulse duration laser with specialized optic for treatment of facial acne scarring.
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Brauer JA, Kazlouskaya Y, Alabdulrazzaq H, Bae YS, Bernstein LJ, Anolik R, Geronemus RG
JAMA Dermatol 2015;151:278-284